Citation Impact
Citing Papers
Stereological Principles for Morphometry in Electron Microscopic Cytology
1969 Standout
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A
1994
Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B
1992
Magnesium basics
2012 Standout
Use of Factor IX Complex in Warfarin-related Intracranial Hemorrhage
1999
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Review: Vertical Transmission of HIV: Parameters Which Might Affect Infection of Placental Trophoblasts by HIV‐1: A Review
1999 StandoutNobel
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
Hepatitis C virus-specific T lymphocyte responses
1995 StandoutNobel
Adult T-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: A clinical, virologic, and familial serologic study
1988 StandoutNobel
Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrate
1987
HIV as the cause of AIDS
1996 StandoutNobel
Complement
2001 Standout
The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings
2003
Disappearance of Hepatitis C Virus RNA in Plasma during Interferon Alpha-2B Treatment in Hemophilia Patients
1992 StandoutNobel
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
The fifth edition of the addiction severity index
1992 Standout
Blood Products for Hemophilia
2004
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Selection of Maternal Human Immunodeficiency Virus Type 1 Variants in Human Placenta
1999 StandoutNobel
Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus
1992 StandoutNobel
Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia
2002 StandoutNobel
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
Development of the human coagulation system in the full-term infant
1987 Standout
Magnesium metabolism
1967
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development
2010 StandoutNobel
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
1992
Intravascular activation of the clotting system with phospholipids. Production of the generalized Shwartzman reaction with platelet factor 3.
1965
Glass bead sterilization of orthodontic bands
1986
The Nature and Significance of Platelet Products in Human Plasma
1967 Standout
Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining.
1992
The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection
1990
Immunopharmacology of the macrophage-toxic agent carrageenan
1979
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients [see comments]
1990
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
1993 Standout
Treatment of Hereditary Angioedema with a Vapor-Heated C1 Inhibitor Concentrate
1996
Hepatitis delta (δ) cDNA clones: Undetectable hybridization to nucleic acids from infectious non‐A, non‐B hepatitis materials and hepatitis B DNA
1987 StandoutNobel
Current Management of Hemophilia B
1993
Pathogenesis of human immunodeficiency virus infection
1993
Beeinflussung einer spezifischen cytoplasmatischen Organelle von Endothelzellen durch Adrenalin
1968
Hepatitis B Virus, Hepatitis Non–A, Non–B Virus and Hepatitis Delta Virus in Lyophilized Antihemophilic Factor: Relative Sensitivity to Heat
1985
Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines
1995
ANTITHROMBIN IN INFANCY AND CHILDHOOD
1975
Antibodies to HTLV‐I in Nigerian blood‐donors, their relatives and patients with leukaemias, lymphomas and other diseases
1986
T helper cell activation and human retroviral pathogenesis
1996
Secretory products of macrophages.
1987 Standout
Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates
1992
Binding of human factor VII and VIIa to monocytes.
1982
Guidelines for the management of hemophilia
2012 Standout
Works of K. Schimpf being referenced
Low risk of viral infection after administration of vapor‐heated factor VIII concentrate
1992
Absence of Anti-Human Immunodeficiency Virus Types 1 and 2 Seroconversion after the Treatment of Hemophilia A or von Willebrand's Disease with Pasteurized Factor VIII Concentrate
1989
Correlation of in vitro Immune Defects with Impaired Gamma Interferon Response in Human‐Immunodeficiency‐Virus‐Infected Individuals
1988
Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous Transfusions
1987
TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE
1985
DIC and postoperative wound bleeding under factor IX substitution therapy in a case of hemophilia B; Successful treatment with heparin
1976
The Influence of the Polysaccharide Carrageenin on the Clotting Mechanism of the Blood in the Rabbit in Vitro and in Vivo
1969
Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany
1985
A comparison of the pro-coagulative and the anti-coagulative actions of the wall of the rabbit aorta
1967
Soluble IL-2 receptor and tumour necrosis factor-α in plasma of haemophilia patients infected with HIV
1992
Antithrombin III und Anti-Blutthrombokinase bei experimenteller Verbrauchskoagulopathie
1961
Die ambulante Dauerbehandlung der Hämophilie A
1976
Zur Frage der Magnesiumwirkung auf die Blutgerinnung
1957